Positive list system may cause to exit long life drugs.

The new NHI reimbursement drug pricing system, called the positive list system may raise primarily for the long living and top seller drugs to exit from the markets.

Mr. Hwang Sang-yeon, an analyst of Mirae Asset Security company, said under the subject of "Korea and U. S. FTA: The third development and starts of new changes" in the celebrating occasion of "the Day of Drug" on Nov. 15 that ...